Biocon [BIOCON] announced a significant 63% year-on-year fall in its fourth-quarter net profit, primarily attributed to exceptional charges. Despite the profit decline, the company showcased growth in its core businesses and successfully completed key strategic integrations, while also recommending a final dividend of ₹0.50.
Biocon Ltd [BIOCON] reported a significant 56.8% decline in Q4 net profit to ₹198.6 crore, primarily impacted by an exceptional item, even as consolidated revenue witnessed growth to ₹4,516.6 crore.
Leading biotech firm Biocon [BIOCON] recently flashed a bullish signal as its Relative Strength Index (RSI) crossed above the 50-mark, indicating strengthening momentum and improved investor sentiment.
Biocon shares saw a positive movement after Chairperson Kiran Mazumdar-Shaw announced her niece, Claire Mazumdar, as her successor, signalling a strategic leadership transition focused on advanced biotech and AI.